Skip to Main Content

A new biotech VC firm started by veterans of the industry began around a whiteboard in two public libraries in suburban Massachusetts.

David Fallace, Richard Lim, and Lou Tartaglia began gathering at the Newton and Wellesley, Mass. libraries in 2021 — locations away from the prying eyes of the Boston biotech ecosystem that also happened to be open during the pandemic — where they could dissect what worked, and what didn’t, in venture capital.


Between the three of them, they had worked at five different venture firms, including Third Rock Ventures, Omega Funds, and Polaris Partners. Fallace invested in even more biotech VC funds through his work at the Alaska Permanent Fund Corp., which routinely gives money to venture capital firms to invest in startups.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.